Home/Filings/4/0002010019-25-000014
4//SEC Filing

Moshkevich Solomon 4

Accession 0002010019-25-000014

CIK 0001604821other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 8:35 PM ET

Size

11.1 KB

Accession

0002010019-25-000014

Insider Transaction Report

Form 4
Period: 2025-12-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Transactions
  • Sale

    Common Stock

    2025-12-01$237.23/sh749$177,683111,312 total
  • Sale

    Common Stock

    2025-12-01$237.77/sh250$59,443111,062 total
  • Sale

    Common Stock

    2025-12-01$238.24/sh1,527$363,797109,535 total
  • Sale

    Common Stock

    2025-12-01$239.53/sh474$113,535109,061 total
Footnotes (5)
  • [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.71 to $237.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.7550 to $237.7850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.44 to $239.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Natera, Inc.

CIK 0001604821

Entity typeother

Related Parties

1
  • filerCIK 0002010019

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 8:35 PM ET
Size
11.1 KB